Literature DB >> 9630846

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin.

P Wolkenstein1, C Tan, S Lecoeur, J Wechsler, N Garcia-Martin, D Charue, M Bagot, P Beaune.   

Abstract

Carbamazepine is an anticonvulsant associated with a high risk for severe cutaneous reactions. Upon metabolism by cytochrome P450, carbamazepine may produce reactive metabolites. We evaluated in vitro the covalent binding of carbamazepine reactive metabolites on human P450s and then the presence of these P450s in human epidermis. Carbamazepine reactive metabolites covalent binding to human liver microsomes involved P450 subfamilies 1A, 2C and 3A. Specific covalent binding to yeasts expressing different P450s showed that carbamazepine reactive metabolites bound specifically to P450 1A2 and 3A4. We confirmed the constitutive presence of P450 3A in human epidermis and after induction with coaltar of P450 1A. Consequently, the production in epidermis of carbamazepine reactive metabolites is theoretically possible with formation of P450 adduct metabolites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630846     DOI: 10.1016/s0009-2797(98)00021-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.

Authors:  Arthur G Roberts; Jing Yang; James R Halpert; Sidney D Nelson; Kenneth T Thummel; William M Atkins
Journal:  Biochemistry       Date:  2011-11-22       Impact factor: 3.162

5.  CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.

Authors:  Ping Kang; Mingxiang Liao; Michael R Wester; J Steven Leeder; Robin E Pearce; Maria Almira Correia
Journal:  Drug Metab Dispos       Date:  2007-12-20       Impact factor: 3.922

6.  Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.

Authors:  Robin E Pearce; Wei Lu; Yongqiang Wang; Jack P Uetrecht; Maria Almira Correia; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2008-05-07       Impact factor: 3.922

7.  Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint.

Authors:  Nusrat Shafiq; Samiksha Bhattacharjee; Samir Malhotra
Journal:  Indian Dermatol Online J       Date:  2022-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.